Immunogen Inc. buy Piper Sandler
Start price
03.05.23
/
50%
€10.66
Target price
03.05.24
€14.47
Performance (%)
171.76%
End price
04.05.24
-
Summary
This prediction is currently being closed. With a performance of 171.76% the BUY prediction by Piper_Sandler is a big success. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunogen Inc. | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by Piper_Sandler for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten